Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
2014 3
2015 1
2016 3
2017 3
2018 2
2019 5
2020 7
2021 3
2022 8
2023 6
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Advances in PET imaging of cancer.
Schwenck J, Sonanini D, Cotton JM, Rammensee HG, la Fougère C, Zender L, Pichler BJ. Schwenck J, et al. Nat Rev Cancer. 2023 Jul;23(7):474-490. doi: 10.1038/s41568-023-00576-4. Epub 2023 May 31. Nat Rev Cancer. 2023. PMID: 37258875 Review.
A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1.
Gallage S, Ali A, Barragan Avila JE, Seymen N, Ramadori P, Joerke V, Zizmare L, Aicher D, Gopalsamy IK, Fong W, Kosla J, Focaccia E, Li X, Yousuf S, Sijmonsma T, Rahbari M, Kommoss KS, Billeter A, Prokosch S, Rothermel U, Mueller F, Hetzer J, Heide D, Schinkel B, Machauer T, Pichler B, Malek NP, Longerich T, Roth S, Rose AJ, Schwenck J, Trautwein C, Karimi MM, Heikenwalder M. Gallage S, et al. Among authors: schwenck j. Cell Metab. 2024 Jun 4;36(6):1371-1393.e7. doi: 10.1016/j.cmet.2024.04.015. Epub 2024 May 7. Cell Metab. 2024. PMID: 38718791 Free article.
PET/MRI Hybrid Systems.
Mannheim JG, Schmid AM, Schwenck J, Katiyar P, Herfert K, Pichler BJ, Disselhorst JA. Mannheim JG, et al. Among authors: schwenck j. Semin Nucl Med. 2018 Jul;48(4):332-347. doi: 10.1053/j.semnuclmed.2018.02.011. Epub 2018 Apr 10. Semin Nucl Med. 2018. PMID: 29852943 Review.
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [64Cu]Cu-NOTA-ch14.18/CHO.
Trautwein NF, Schwenck J, Seitz C, Seith F, Calderón E, von Beschwitz S, Singer S, Reischl G, Handgretinger R, Schäfer J, Lang P, Pichler BJ, Schulte JH, la Fougère C, Dittmann H. Trautwein NF, et al. Among authors: schwenck j. Theranostics. 2024 Jan 20;14(3):1212-1223. doi: 10.7150/thno.92481. eCollection 2024. Theranostics. 2024. PMID: 38323317 Free PMC article.
bp: Blood pressure analysis in R.
Schwenck J, Punjabi NM, Gaynanova I. Schwenck J, et al. PLoS One. 2022 Sep 9;17(9):e0268934. doi: 10.1371/journal.pone.0268934. eCollection 2022. PLoS One. 2022. PMID: 36083882 Free PMC article.
CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients.
Sonanini D, Schwenck J, Blaess S, Schmitt J, Maurer A, Ehrlichmann W, Ritter M, Skokowa J, Kneilling M, Jung G, Fend F, Krost S, Seitz CM, Lang P, Reischl G, Handgretinger R, Fougère C, Pichler BJ. Sonanini D, et al. Among authors: schwenck j. Biomark Res. 2024 May 12;12(1):50. doi: 10.1186/s40364-024-00595-9. Biomark Res. 2024. PMID: 38735945 Free PMC article.
Long-term prognostic factors for PRRT in neuroendocrine tumors.
Trautwein NF, Schwenck J, Jacoby J, Reischl G, Fiz F, Zender L, Dittmann H, Hinterleitner M, la Fougère C. Trautwein NF, et al. Among authors: schwenck j. Front Med (Lausanne). 2023 Jun 9;10:1169970. doi: 10.3389/fmed.2023.1169970. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37359009 Free PMC article.
Quantification of intratumoural heterogeneity in mice and patients via machine-learning models trained on PET-MRI data.
Katiyar P, Schwenck J, Frauenfeld L, Divine MR, Agrawal V, Kohlhofer U, Gatidis S, Kontermann R, Königsrainer A, Quintanilla-Martinez L, la Fougère C, Schölkopf B, Pichler BJ, Disselhorst JA. Katiyar P, et al. Among authors: schwenck j. Nat Biomed Eng. 2023 Aug;7(8):1014-1027. doi: 10.1038/s41551-023-01047-9. Epub 2023 Jun 5. Nat Biomed Eng. 2023. PMID: 37277483
Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study.
Trautwein NF, Hinterleitner C, Kiefer LS, Singer S, Mattern S, Schwenck J, Reischl G, Sipos B, Lauer UM, Dittmann H, Zender L, la Fougère C, Hinterleitner M. Trautwein NF, et al. Among authors: schwenck j. Clin Nucl Med. 2024 Mar 1;49(3):207-214. doi: 10.1097/RLU.0000000000005006. Epub 2024 Jan 23. Clin Nucl Med. 2024. PMID: 38271237 Free PMC article.
40 results